Eli Lilly just released impressive study results for retatrutide, an investigational weight loss drug that targets three ...

If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...

A groundbreaking gene therapy, VERVE-102, has shown promise in reducing "bad" cholesterol by up to 62% with a single ...

Switching from daily pills for life to a single injection could revolutionise cholesterol treatment, especially for those ...

Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, ...

Experts say that the gene therapy could prove 'transformative' for patients by preventing future heart attacks or strokes.

VERVE-102 is an investigational gene-editing treatment designed to permanently disable the PCSK9 gene in the liver, thereby ...

One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...

My generation—which is to say, the pillbox generation—came of age during the 1990s. The number of adults who were taking five ...

A new way of managing harmful blood fats is emerging in the form of novel gene-editing treatments designed to inactivate or ...

Those most likely to benefit from steroid injections have persistent pain which disrupts sleep and who find other medications ...

A one-time gene-editing infusion kept cholesterol levels low for a year, offering a potential new approach to preventing ...